drugset / Trial / NCT02107313
Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2
RandomizedCrossoverOpen-labelBasic science
Summary
This study is designed to determine the pharmacokinetic (PK) profile of a single oral dose of PBT2 administered to healthy volunteers in the presence and absence of food.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-06
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBT2 | Small molecule | 250 mg | Oral |
Indications
No indication recorded.